The Vox Markets Podcast

• 2263: Small Cap Investing with Paul Hill and Paul Scott

  Watch on Youtube In this week’s smallcap investing show, UK equity analyst & markets commentator Paul Scott & I discussed our thoughts on 19 stocks. Also watch out for next week’s Xmas Special at 2pm Wedn 17th Dec. 00:00 Recent buys or sells. 01:20 XP Factory 07:10 Everyman Media 11:25 Big Technologies 16:30 What’s going to trigger a UK smallcap rally? 23:30 Topps Tiles 26:55 Begbies Traynor 31:40 Applied Nutrition 35:00 Ashtead Technology 40:25 Venture Life 44:00 Cohort 46:20 RWS 50:15 System1 56:05 Made Tech 59:50 Oxford Metrics 1:03:40 ME Group 1:07:20 Tate & Lyle 1:10:10 Mears 1:12:40 Restore 1:15:30 Thruvision 1:19:25 Northern Bear XPF #EMAN #BIG #TPT #BEG #APN #AT. #VLG #CHRT #RWS #SYS1 #MTEC #OMG #MEG #TATE #MER #RST #THRU #NTBR ------------------------------------------------------------ Follow us: X (Twitter): https://x.com/VOXmarkets LinkedIn: https://www.linkedin.com/company/vox-markets/ TikTok: https://www.tiktok.com/@voxmarkets Listen to our podcast: Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-vox-markets-podcast/id1569138869 Spotify: https://open.spotify.com/show/1noGnZw4hFfNgspb4puAlX Learn more: https://www.voxmarkets.com

  --------  

  1:23:54

  --------

  1:23:54
• 2262: Lithium good times are here again, and Kodal has started shipping

  Watch on YouTube Bernard Aylward, the CEO of Kodal Minerals #KOD, joins Vox to talk about the company's nascent lithium production project in Mali, how it's going and what the expansion plans are. Set in motion with an initial US$65 million in capital, the Bougouni project is now up and running, with plans to develop a much larger, stage 2 operation in 2026. In the background, the lithium price has improved markedly, and the mining sector in general has come alive as Kodal has got Bougouni going. So, says Aylward, 2025 was a very good year, and 2026 could be even better ------------------------------------------------------------ Follow us: X (Twitter): https://x.com/VOXmarkets LinkedIn: https://www.linkedin.com/company/vox-markets/ TikTok: https://www.tiktok.com/@voxmarkets Listen to our podcast: Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-vox-markets-podcast/id1569138869 Spotify: https://open.spotify.com/show/1noGnZw4hFfNgspb4puAlX Learn more: https://www.voxmarkets.com

  --------  

  42:37

  --------

  42:37
• 2261: Q&A with IXICO CEO Bram Goorden and CFO Grant Nash

  Watch on Youtube In this upbeat interview, CEO Bram Goorden and CFO Grant Nash of IXICO #IXI - an AI powered medical imaging analytics firm - take me through today’s strong & slightly better than expected FY’25 results, including: 00:00 What’s been driving the powerful top line growth & current demand picture. 06:15 Financial highlights 09:15 Top level strategic glide path from FY’25 sales of £6.5m to £10m in the medium term and ultimately £20m. 13:50 FY’26 outlook 16:15 Closing remarks ------------------------------------------------------------ Follow us: X (Twitter): https://x.com/VOXmarkets LinkedIn: https://www.linkedin.com/company/vox-markets/ TikTok: https://www.tiktok.com/@voxmarkets Listen to our podcast: Apple Podcasts: https://podcasts.apple.com/gb/podcast/the-vox-markets-podcast/id1569138869 Spotify: https://open.spotify.com/show/1noGnZw4hFfNgspb4puAlX Learn more: https://www.voxmarkets.com

  --------  

  18:11

  --------

  18:11
• 2260: MedPal Transforming Wellness: AI, Epassi, and the Future of Preventive Health

  In this exclusive interview, MedPal’s CEO Jason Drummond joins us to discuss the company’s latest RNS, revealing a major upgrade to its AI-powered wellness app and a strategic rollout to over 11 million users via Epassi UK’s gym network.

  --------  

  10:01

  --------

  10:01
• 2259: Poolbeg Just Landed a Game-Changer

  Poolbeg Pharma (AIM: POLB) has announced that its lead asset, POLB 001, will play a central role in the new RISE research programme, a groundbreaking initiative tackling cytokine release syndrome (CRS) caused by cancer immunotherapy. In this interview, CEO Jeremy Skillington and Scientific Advisor Liam Loughrey explain what this means for the company, how the collaboration with leading academic and medical institutions came about, and what the implications are for patients and shareholders alike.

  --------  

  7:21

  --------

  7:21

More Business podcasts

Trending Business podcasts

About The Vox Markets Podcast